Aridis Pharmaceuticals, Inc. Made Big Gain

Thu, Jul 28, 2022 at 07:05 PM
Aridis Pharmaceuticals, Inc. Made Big Gain

Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ) shot up at $1.92, a gain of 37.1%. On Thu, Jul 28, 2022, ARDS:NASDAQ hit a New 2-Week High of $1.92. The stock appeared on our News Catalysts scanner on Fri, Jul 01, 2022 at 02:18 PM in the 'BIOTECH' category. From Thu, Jul 14, 2022, the stock recorded 70.00% Up Days and 36.36% Green Days

The stock spiked on Thu, Feb 17, 2022 at $2.94 with a volume of 3M+.

About Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ)

Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.